Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,838
Closed -$454K 364
2016
Q2
$454K Sell
10,838
-3,160
-23% -$130K ﹤0.01% 321
2016
Q1
$562K Sell
13,998
-2,600
-16% -$104K 0.01% 297
2015
Q4
$708K Sell
16,598
-708
-4% -$32.6K 0.01% 274
2015
Q3
$821K Buy
17,306
+2,395
+16% +$122K 0.01% 257
2015
Q2
$739K Sell
14,911
-8,135
-35% -$412K 0.01% 259
2015
Q1
$1.14M Sell
23,046
-442
-2% -$21.1K 0.01% 225
2014
Q4
$1.07M Buy
23,488
+2,273
+11% +$110K 0.01% 229
2014
Q3
$1.2M Sell
21,215
-15
-0.1% -$806 0.02% 205
2014
Q2
$1.13M Buy
21,230
+232
+1% +$12.3K 0.02% 212
2014
Q1
$1.1M Buy
20,998
+1,931
+10% +$97.7K 0.02% 206
2013
Q4
$1.02M Buy
19,067
+882
+5% +$45.5K 0.02% 211
2013
Q3
$921K Sell
18,185
-317
-2% -$16.1K 0.02% 195
2013
Q2
$953K Buy
+18,502
New +$986K 0.02% 191

Other funds holding SNY

TIAA CREF Trust's SNY Position: Q3 2016 in Review

TIAA CREF Trust sold out of Sanofi (SNY) in Q3 2016, closing a stake of 10,838 shares — an estimated $454K sold.

TIAA CREF Trust first reported a position in SNY in Q2 2013 and held it in 13 quarters. The position peaked at $1.2M in Q3 2014. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

  • TIAA CREF Trust reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
  • TIAA CREF Trust sold 10,838 Sanofi shares in Q3 2016, an estimated $454K.
  • TIAA CREF Trust first reported a position in Sanofi in Q2 2013 and held it in 13 quarters.
  • TIAA CREF Trust's Sanofi position peaked at $1.2M in Q3 2014.
  • 450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on TIAA CREF Trust's 13F filing for Q3 2016, filed 4 Nov 2016.